Online citations, reference lists, and bibliographies.
← Back to Search

Botulinum Toxin Type A Management Of Spasticity In The Context Of Orthopaedic Surgery For Children With Spastic Cerebral Palsy

H. Graham
Published 2001 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cerebral palsy is the most common cause of physical disability affecting children in developed countries. Although cerebral palsy is, by definition, a ‘static encephalopathy’ the associated musculoskeletal pathology is progressive and current definitions are therefore somewhat inadequate. Understanding the stages of the musculoskeletal pathology is fundamental to understanding current management strategies, including spasticity management, strengthening programmes and deformity correction by orthopaedic surgery. In this review, a number of new management strategies are described, in which spasticity management by intramuscular injections of botulinum toxin type A and deformity correction, by orthopaedic surgery, are combined.
This paper references
10.1097/00001577-200012020-00009
The Effect of Botulinum Toxin A on Gastrocnemius Length: Magnitude and Duration of Response
Corinne S. Taylor (2000)
Validity of a clinical measure of spasticity in children with cerebral palsy in a randomized clinical trial . American Academy of Cerebral Palsy San Antonio ( AACPDM ) [ Abstract ]
R Boyd
10.1136/ADC.83.3.279A
Cerebral palsies: epidemiology and causal pathways
A. Johnson (2000)
10.1302/0301-620X.58B1.1270500
The importance of gastrocnemius recession in the correction of equinus deformity in cerebral palsy.
J. Craig (1976)
The e€ect of Botulinum Toxin A on the functional ability of the child with spastic hemiplegia: a randomized controlled trial
SC Love (2001)
Multiple lower extremity orthopaedic procedures: the e€ect on the energy cost of walking
CA Olesch (1999)
Analgesic e€ects
C Baillieu (2000)
10.1177/088307389000500303
Spasticity in Cerebral Palsy and the Selective Posterior Rhizotomy Procedure
W. Peacock (1990)
10.1097/00003086-199303000-00018
Common gait abnormalities of the knee in cerebral palsy.
D. Sutherland (1993)
The e€ect of immobilization on the longitudinal growth of striated muscle ®bres
PE Williams (1973)
Validity of a clinical measure of spasticity in children with cerebral palsy in a randomized clinical trial
R Boyd (1998)
10.1111/j.1469-8749.1994.tb11864.x
BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY
A. Cosgrove (1994)
10.1111/j.1468-1331.1999.tb00034.x
Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome
F. Heinen (1999)
10.1016/0022-510X(79)90169-2
Trophic muscle regulation in children with congenital cerebral lesions
C. Tardieu (1979)
10.1152/AJPLEGACY.1928.86.2.312
THE ELASTICITY AND DUCTILITY OF MUSCLE IN THE MYOSTATIC CONTRACTURE CAUSED BY TETANUS TOXIN
S. W. Ranson (1928)
10.1046/j.1468-1331.2001.00038.x
The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial
S. Love (2001)
10.1111/j.1469-8749.1994.tb11863.x
BOTUNUM TOXIN A PREVENTS THE DEVELOPMENT OF CONTRACTURES IN THE HEREDITARY SPASTC MOUSE
A. Cosgrove (1994)
Preserving plantar ̄exion strength after surgical treatment for contracture of the triceps surae: a computer simulation study
SL Delp (1995)
Mechanisms of spasticity.
J. Lance (1974)
10.1016/S0025-6196(12)61052-0
The Art and Practice of Children's Orthopaedics
H. Peterson (1994)
10.1111/j.1469-8749.1999.tb00589.x
The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response
N. Eames (1999)
10.1159/000057133
Die Wirkung der Selbsthypnose bei Patienten mit Pollinosis
A. Bircher (1999)
10.1097/00003086-197109000-00010
Cerebral palsy. Spastic varus and forefoot adductus, treated by intramuscular posterior tibial tendon lengthening.
R. Rudà (1971)
10.1046/j.1468-1331.2001.00041.x
Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences
G. Molenaers (2001)
10.1111/j.1468-1331.1999.tb00035.x
Botulinum toxin type A treatment of cerebral palsy: an integrated approach
G. Molenaers (1999)
10.1177/088307389601100202
Topical Review: Baclofen in the Treatment of Cerebral Palsy
A. Albright (1996)
10.1177/0883073896011001S05
Intrathecal Baclofen in Cerebral Palsy Movement Disorders
A. Albright (1996)
Use of objective clinical measures in predicting response to botulinum toxin A in children with cerebral palsy
R Boyd (1998)
The e€ect of intrathecal baclofen therapy on gait in children with cerebral palsy
F Motta (2000)
10.1111/j.1469-8749.1995.tb15019.x
MUSCLE RESPONSE TO HEAVY RESISTANCE EXERCISE IN CHILDREN WITH SPASTIC CEREBRAL PALSY
D. Damiano (1995)
10.1111/j.1469-8749.1997.tb07408.x
Botulinum toxin A in the hemiplegia upper limb: a double‐blind trial
I. S. Corry (1997)
E € ects of quadriceps femoris muscle strengthening on crouch gait in children with spastic diplegia
DL Damiano
The effect of immobilization on the longitudinal growth of striated muscle fibres.
P. E. Williams (1973)
10.1017/S0012162299000018
Joining the mainstream.
M. Bax (1999)
[Research on a technic for measurement of spasticity].
G. Tardieu (1954)
10.1046/j.1468-1331.2001.00037.x
Spasticity versus strength in cerebral palsy: relationships among involuntary resistance, voluntary torque, and motor function
D. Damiano (2001)
10.1111/j.1468-1331.1999.tb00031.x
Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
R. Boyd (1999)
10.1007/BF01025189
Symposium synopsis
(1986)
10.1177/088307380001500402
Evaluation of Botulinum Toxin A Therapy in Children With Adductor Spasm by Gross Motor Function Measure
V. Mall (2000)
10.1046/j.1468-1331.1999.610023.x
Influence of learning to read and write on the morphology of the corpus callosum
A. Castro-Caldas (1999)
Split Posterior Tibial Tendon Transfer: The Universal Procedure
NE Green (1991)
10.1097/00001577-199801020-00013
Botulinum Toxin A in the Hemiplegic Upper Limb: A Double‐blind Trial
L. Arens (1997)
10.1136/adc.76.4.381
Surveillance measures of the hips of children with bilateral cerebral palsy
D. Scrutton (1997)
The pathophysiology of spasticity and dystonia
JP Lin (2000)
10.1007/978-3-319-50592-3
[Cerebral palsy].
P. Grimaud (1972)
10.1097/01241398-199707000-00014
Split tibialis posterior tendon transfer in the treatment of spastic equinovarus foot.
J. O’byrne (1997)
10.1016/0378-3782(90)90002-Z
White matter damage in preterm newborns--an epidemiologic perspective.
A. Leviton (1990)
10.1111/j.1469-8749.2000.tb00056.x
Analgesic effects of botulinum toxin A: a randomized, placebo‐controlled clinical trial
S. Barwood (2000)
Wenger, DR, Rang, M eds
M Rang (1993)
Management of functional limitations at the knee in ambulatory children with cerebral palsy
CL Colton (2001)
10.1046/j.1468-1331.2001.00039.x
Treatment of functional limitations at the knee in ambulatory children with cerebral palsy
H. Chambers (2001)
10.1111/j.1468-1331.1999.tb00033.x
Medium‐term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy
R. Boyd (1999)
10.1159/000057155
Einige praxisrelevante Aspekte der Pharmakokinetik von THC
F. Grotenhermen (1999)
Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse.
A. Cosgrove (1994)
10.1302/0301-620X.58B2.932084
Transposition of the tendon of pronator teres in cerebral palsy.
C. Colton (1976)
10.1111/j.1469-8749.1984.tb04412.x
MUSCLE GROWTH IN NORMAL AND SPASTIC MICE
I. Ziv (1984)
Cerebral palsies: an overview
G Miller (1998)
10.1002/MUS.880040305
Experimental rapid sarcomere loss with concomitant hypoextensibility
J. Tabary (1981)
Complications in Cerebral Palsy Treatment
F Miller (1995)
10.1302/0301-620X.83B3.10827
Isolated calf lengthening in cerebral palsy. Outcome analysis of risk factors.
D. Borton (2001)
10.1016/S0966-6362(99)00037-5
Botulinum toxin A in hamstring spasticity.
I. Corry (1999)
A la recherche d'une technique de mesure de la spasticité.
G. Tardieu (1954)
10.1046/j.1468-1331.1999.610051.x
Stroke following internal carotid artery occlusion — a contra‐indication for intravenous thrombolysis?
J. Rudolf (1999)
Intrathecal baclofen in cerebral palsy
AL Albright (1996)
Bone Joint Surg (Br) 58:84±87
J cerebral palsy (1995)
10.1016/0022-510X(79)90198-9
Decrease of muscle extensibility and reduction of sarcomere number in soleus muscle following a local injection of tetanus toxin
E. H. Tour (1979)
Botulinum toxin A in the management of children with cerebral palsy: indications and outcome
R. Boyd (1997)
10.1111/j.1468-1331.1997.tb00295.x
Correlates of leukoaraiosis and ventricular enlargement on magnetic resonance imaging: a study in normal elderly and cerebrovascular patients
A. Padovani (1997)
10.1046/j.1468-1331.2001.00040.x
A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures
K. Desloovere (2001)
Analgesic e € ects of botulinum toxin A : a randomized , placebo - controlled clinical trial
DC Borton (2000)
Recession of the gastrocnemius
LM Strayer (1950)
10.1016/S0140-6736(89)92935-8
Spasticity
A. Brashear (1984)
Selective posterior rhizotomy for the relief of spasticity in cerebral palsy.
W. Peacock (1982)
10.1002/JOR.1100130115
Preserving plantar flexion strength after surgical treatment for contracture of the triceps surae: A computer simulation study
S. Delp (1995)
10.1152/AJPCELL.1980.238.1.C62
Stretch-induced growth in chicken wing muscles: a new model of stretch hypertrophy.
R. Holly (1980)



This paper is referenced by
10.1111/dmcn.12200
Muscle volume alterations in spastic muscles immediately following botulinum toxin type‐A treatment in children with cerebral palsy
Sîan A Williams (2013)
10.1016/J.ANNRMP.2007.12.007
Measuring quality of life in cerebral palsy children..
E. Viehweger (2008)
The use of Botulinum toxin in Management of Spasticity and a review of injection techniques in relation to children with cerebral palsy
(2009)
10.1016/J.GAITPOST.2006.11.101
Pilot protocol evaluation for a randomised clinical trial: The effectiveness of single event multilevel surgery for children with cerebral palsy
Pam Thomason (2006)
10.1046/j.1468-1331.2001.00048.x
Management of upper limb dysfunction in children with cerebral palsy: a systematic review
R. Boyd (2001)
10.1097/00004694-200409000-00012
Uptime in Children With Cerebral Palsy
M. Pirpiris (2004)
10.1080/01942638.2020.1720055
Walking Performance, Physical Activity, and Validity of the Early Activity Scale for Endurance in Young Children with Cerebral Palsy
E. Wentz (2020)
14 Physiotherapy for Children with Cerebral Palsy
M. Günel (2017)
10.1055/S-0038-1626208
Rizotomia dorsal seletiva (RDS) para espasticidade: técnica minimamente invasiva no cone medular
A. Kiss (2014)
Use of intrathecal baclofen in a pediatric cerebral palsy patient with refractory hemiplegia to maintain orthopaedic surgery gains.
L. Lai (2008)
10.2106/00004623-200411000-00003
Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
R. Kay (2004)
10.1016/j.ridd.2011.10.026
The use of night orthoses in cerebral palsy treatment: sleep disturbance in children and parental burden or not?
E. Mol (2012)
10.1016/J.GAITPOST.2006.01.003
Gait classification in children with cerebral palsy: a systematic review.
F. Dobson (2007)
Unizentrische Kohortenstudie zum integrativen Therapiekonzept bei Kindern mit bilateral spastischer Cerebralparese unter besonderer Berücksichtigung der Adhärenz zu der Behandlung mit Botulinumtoxin
C. Klein (2013)
10.2106/JBJS.D.03054
Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat.
J. Ma (2007)
10.1016/B978-1-4160-4928-9.00014-7
Chapter 14 – Treatment of Motor Disorders in Cerebral Palsy with Botulinum Neurotoxin
J. Leonard (2009)
10.3233/NRE-141107
Changes in spastic muscle stiffness after botulinum toxin A injections as part of rehabilitation therapy in patients with spastic cerebral palsy.
A. Boyacı (2014)
10.1016/j.annrmp.2007.12.002
Measuring quality of life in cerebral palsy children..
E. Viehweger (2008)
10.1186/1471-2431-12-53
Static balance and function in children with cerebral palsy submitted to neuromuscular block and neuromuscular electrical stimulation: Study protocol for prospective, randomized, controlled trial
Soráia Kazon (2012)
10.2106/JBJS.J.02003
Adductor surgery to prevent hip displacement in children with cerebral palsy: the predictive role of the Gross Motor Function Classification System.
B. Shore (2012)
10.1017/S0012162203001403
Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
M. Bottos (2003)
10.1007/s00112-009-2040-8
Botulinumtoxin als Teil einer integrierten Behandlung
A. Schroeder (2009)
10.1302/0301-620X.87B4.15525
Multilevel orthopaedic surgery in group IV spastic hemiplegia.
H. Graham (2005)
10.1016/S0749-0712(03)00060-X
Botulinum toxin A in the management of upper limb spasticity in cerebral palsy.
Terence Y P Chin (2003)
10.1111/JPPI.12139
Context-Dependency of Mobility in Children and Adolescents With Cerebral Palsy: Optimal and Natural Environments
A. Kleiner (2015)
10.1111/j.1469-8749.2003.tb00885.x
Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment
M. Bottos (2003)
10.1016/j.ocl.2010.06.001
Assessment and treatment of movement disorders in children with cerebral palsy.
Laura L Deon (2010)
10.1111/j.1469-8749.2006.tb01356.x
Activities of daily living in children with hemiplegic cerebral palsy: a cross‐sectional evaluation using the Assessment of Motor and Process Skills
B R Van (2006)
10.1017/S0012162206001551
Activities of daily living in children with hemiplegic cerebral palsy: a cross-sectional evaluation using the Assessment of Motor and Process Skills.
B. R. Van Zelst (2006)
Evaluation du traitement de l' equin chez l'enfant par la toxine botulique : approche multidisciplinaire au centre hospitalier d'Annecy
V. Seetha (2008)
10.1097/PHM.0b013e31817fa167
Anatomic Localization of Motor Points for the Neuromuscular Blockade of Hand Intrinsic Muscles Involved in Thumb-in-Palm
Sun Im (2008)
10.1016/S0140-6736(02)08015-7
Painful hip dislocation in cerebral palsy
H. Graham (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar